eXoZymes Inc. Common Stock

EXOZNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
9.34 USD
↘ 0.01 (0.11%)AT CLOSE (11:59 AM EDT)
9.21
↘ 0.14 (1.45%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
9.21
↘ 0.14 (1.45%)
🔴Market: CLOSED
Open?$9.45
High?$10.23
Low?$8.97
Prev. Close?$9.35
Volume?4.7K
Avg. Volume?3.6K
VWAP?$9.43
Rel. Volume?1.31x
Bid / Ask
Bid?$8.97 × 300
Ask?$11.19 × 500
Spread?$2.22
Midpoint?$10.08
Valuation & Ratios
Market Cap?79.2M
Shares Out?8.5M
Float?2.5M
Float %?29.7%
P/E Ratio?N/A
P/B Ratio?51.83
EPS?-$1.14
Dividend?0.00%
Ex-Dividend?N/A

eXoZymes Inc. Common Stock (EXOZ) trades at $9.34 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsEnvironmental & Sustainability›Sustainable Packaging & Materials
Employees
32
Market Cap
79.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.exozymes.com
Listed
2024-11-13
Address
750 ROYAL OAKS DR
MONROVIA, CA 91016
Phone: (626) - 415 - 1488
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
62
Momentum?
50
Short Sent.?
78
Piotroski F-Score?0/9Weak
Altman Z-Score?2.71Grey
Confidence?38%Very Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.48%Low
Short Interest?12.0K
Days to Cover?5.0
Free Float2.5M
Avg Daily Volume2.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.32Adequate
Quick Ratio?1.32Adequate
Cash Ratio?0.91Adequate
Debt/Equity?0.06Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
51.83HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-633.0%WEAK▾
ROA?
S&P
3
-240.7%WEAK▾
Cash Flow & Enterprise
FCF?$-7089423
Enterprise Value?$77.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist